Search Results - "Ellis, Lorie A"

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Gaylis, Franklin D, Emond, Bruno, Manceur, Ameur M, Tardif-Samson, Anabelle, Morrison, Laura, Pilon, Dominic, Lefebvre, Patrick, Ellis, Lorie A, Balaji, Hiremagalur, Ireland, Andrea

“…Bacillus Calmette-Guérin (BCG) can reduce recurrence and delay progression among patients with high-risk non-muscle invasive bladder cancer (NMIBC), but is…”
Get full text

Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study by Hudesman, David P, Chakravarty, Soumya D, Emond, Bruno, Ellis, Lorie A, Lefebvre, Patrick, Sadik, Kay, Scher, Jose U

“…Chronic inflammatory diseases (CIDs; ankylosing spondylitis [AS], psoriatic arthritis [PsA], psoriasis [PsO], or rheumatoid arthritis [RA]) and inflammatory…”
Get full text

Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors by Emond, Bruno, Ellis, Lorie A., Chakravarty, Soumya D., Ladouceur, Martin, Lefebvre, Patrick

“…Objectives: (1) To assess the real-world incidence of inflammatory bowel disease (IBD) in patients with or without other chronic inflammatory diseases (CIDs),…”
Get full text

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide by Behl, Ajay S, Ellis, Lorie A, Pilon, Dominic, Xiao, Yongling, Lefebvre, Patrick

“…The efficacy of and overall survival associated with metastatic castration-resistant prostate cancer (CRPC) treatments rely on patients' consistent adherence…”
Get full text

Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer by Pilon, Dominic, Queener, Marykay, Lefebvre, Patrick, Ellis, Lorie A

“…To calculate costs per median overall survival (OS) month in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) treated…”
Get more information

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis by Vanderpoel, Julie, Emond, Bruno, Ghelerter, Isabelle, Milbers, Katherine, Lafeuille, Marie-Hélène, Lefebvre, Patrick, Ellis, Lorie A.

“…Background An estimated 10–15% of non-small cell lung cancer (NSCLC) cases present with epidermal growth factor receptor mutation (EGFRm). While EGFR tyrosine…”
Get full text

Consideration of Potential Drug-Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer by Pilon, Dominic, Ellis, Lorie A, Xiao, Yongling, Behl, Ajay S, Lefebvre, Patrick

Get full text

Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide by Pilon, Dominic, Behl, Ajay S, Ellis, Lorie A, Emond, Bruno, Lefebvre, Patrick, Dawson, Nancy A

“…Abiraterone acetate (AA) and enzalutamide (ENZ) are oral therapies offering survival benefit to metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text

Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy by Pilon, Dominic, Behl, Ajay S, Ellis, Lorie A, Robitaille, Marie-Noëlle, Lefebvre, Patrick, Dawson, Nancy A

“…Central nervous system (CNS) events are frequently reported among patients with advanced prostate cancer as a consequence of the treatments used in this…”
Get full text

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab by Yazici, Yusuf, Xie, Lin, Ogbomo, Adesuwa, Ellis, Lorie A, Goyal, Kavitha, Teeple, Amanda, Simsek, Ismail

“…This study compared treatment patterns of Turkish patients with a diagnosis of rheumatoid arthritis (RA) who were treated with innovator Remicade (infliximab…”
Get full text

Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept by Dehoratius, Raphael J., Brent, Lawrence H., Curtis, Jeffrey R., Ellis, Lorie A, Tang, Kezhen L.

“…Background Patient perceptions of treatment success, including satisfaction/preference, may complement clinical efficacy assessments. Objective Our objective…”
Get full text

A descriptive analysis of real-world treatment patterns of innovator (Remicade ® ) and biosimilar infliximab in an infliximab-naïve Turkish population by Yazici, Yusuf, Xie, Lin, Ogbomo, Adesuwa, Ellis, Lorie A, Goyal, Kavitha, Teeple, Amanda, Mutlu, Ece A, Simsek, Ismail

“…Biosimilar IFX (CT-P13) received marketing approval in Turkey for treatment of rheumatologic diseases, including ankylosing spondylitis, psoriatic arthritis,…”
Get full text

Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer by Ellis, Lorie A, Lafeuille, Marie-Hélène, Gozalo, Laurence, Pilon, Dominic, Lefebvre, Patrick, McKenzie, Scott

“…The approval of new therapies for metastatic castration-resistant prostate cancer (mCRPC), including the oral agents abiraterone acetate and enzalutamide, has…”
Get full text

Quality process measures for rheumatoid arthritis: performance from members enrolled in a national health plan by Tkacz, Joseph, Ellis, Lorie A, Meyer, Roxanne, Bolge, Susan C, Brady, Brenna L, Ruetsch, Charles

“…Health care quality problems are reflected in the underuse, overuse, and misuse of health care services. There is evidence suggesting that the quality of…”
Get full text

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab by Ellis, Lorie A, Malangone-Monaco, Elisabetta, Varker, Helen, Stetsovsky, Diana, Kubacki, Maureen, DeHoratius, Raphael J, Kafka, Shelly

“…The objectives of this study were to evaluate and compare treatment patterns and infusion-related health care resource expenditures for rheumatoid arthritis…”
Get full text

Assessment of Evidence-Based Standards in the Treatment of Advanced Prostate Cancer in a Community Practice by Pilon, Dominic, Ellis, Lorie A, Behl, Ajay S, Gozalo, Laurence, Emond, Bruno, Lefebvre, Patrick, Calabrese, Renee, Prime, Hilary, Gaylis, Franklin

“…INTRODUCTIONAlthough the monitoring of patients with advanced prostate cancer is essential to optimize treatment, little is known about adherence to…”
Get full text

Do milk-borne cytokines and hormones influence neonatal immune cell function? by Ellis, L A, Mastro, A M, Picciano, M F

“…Cytokines, growth factors and various hormones collectively control the proliferation, survival, differentiation and function of immune cells. A wide array of…”
Get more information

Breastfeeding and the working mother: effect of time and temperature of short-term storage on proteolysis, lipolysis, and bacterial growth in milk by Hamosh, M. (Georgetown University Medical Center, Washington, DC.), Ellis, L.A, Pollock, D.R, Henderson, T.R, Hamosh, P

“…Background. Women who breastfeed have to store expressed milk while at work for later feeding to their infants; however, storage conditions are often not…”
Get full text

Consideration of Potential Drug–Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer by Pilon, Dominic, Ellis, Lorie A., Xiao, Yongling, Behl, Ajay S., Lefebvre, Patrick

Get full text

Milk-borne prolactin and neonatal development by Ellis, L A, Mastro, A M, Picciano, M F

“…Milk is primarily regarded as a food furnishing essential nutrients for infant growth and development, but milk can also serve as a vehicle for mother to…”
Get full text